DPP-IV Inhibitors Underlying Mechanism of Cancer in Diabetic Patients

NCT01588587 · clinicaltrials.gov ↗

UNKNOWN

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Sitagliptin
DRUG: Alogliptin
DRUG: Vildagliptin

Sponsor

Nagaoka Red Cross Hospital

Collaborators

[object Object]